BioSpace News Archive

New research conducted by Health Data Analytics Institute (HDAI), in collaboration with researchers at the Cleveland Clinic, is being presented as a featured abstract at the 2022 Annual meeting of the American Society of Anesthesiologists on October 22 in New Orleans and will soon be published as a feature article in Anesthesiology, the Society’s journal.

The commercial success of monoclonal antibodies in major pharmaceutical markets sparked the development of multispecific antibodies.

According to Nova one advisor, the global Cell Separation market size is expected to hit around USD 30.8 billion by 2030 from valued at USD 7.6 billion in 2021 and growing at a CAGR of 19.8% from 2022 to 2030

According to Nova one advisor, the global Upstream Bioprocessing market size was valued at USD 10.60 billion in 2021 and is predicted to hit USD 22.9 billion by 2030 with a registered CAGR of 16.4% during the forecast period 2022 to 2030.

Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced three posters will be presented at the American Society of Nephrology (ASN) Kidney Week 2022 to be held November 3-6, 2022, in Orlando, Florida.

TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the third quarter of 2022 after market close on Thursday, November 3, 2022.

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its third quarter 2022 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, November 3, 2022.

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, November 4, 2022 to discuss its third quarter 2022 operating results.

NyxoahSA announced that the Company will participate in the Jefferies London Healthcare Conference, which takes place November 15-17, 2022, at The Waldorf Hilton in London.

Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced that abstracts highlighting clinical data for omaveloxolone and disease education data on Friedreich’s ataxia will be presented at the International Congress for Ataxia Research 2022 (“ICAR”) being held in Dallas, TX from November 1 – 4, 2022.